3100SR Prostatic Acid Phosphatase with serial reporting

Components
NAME METHOD REFERENCE RANGE UNITS
Prostatic Acid Phosphatase ICMA  < 3.50  ng/mL 


Specimen Requirements
TYPE VOLUME TEMPERATURE INSTRUCTIONS
PRIMARY
1 Serum 2 (0.8) mL   Ambient - 7 Day(s), Refrigerated - 7 Day(s), Frozen - 2 Month(s)  


Clinical utility
An adjunct in the evaluation of possible prostatic malignancy and useful in monitoring therapeutic progress. Diagnose carcinoma of prostate, metastatic; monitor therapy with antineoplastic drugs in prostatic cancer; evaluate possible histiocytosis. Moderate elevations of total acid phosphatase have been observed with malignant invasion of bone, myelocytic leukemia, Paget's disease, hyperparathyroidism with skeletal involvement, Gaucher's disease, and Neimann-Pick disease. Spurious elevations may occur in hemolytic disease and impaired kidney function.


Reported: Same day

CPT Code: 84066